CIK 0001680581
- Non-accelerated filer
- Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474839948
- Phone
- +1 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-19 | Stuart Bryan See Remarks | Grant or award · Stock Option (right to buy) | +340,000 | 340,000 | ||
| 2021-08-11 | Stuart Bryan See Remarks | Option exercise | +28,000 | $7.84 | $220K | 28,000 |
| 2021-08-11 | Stuart Bryan See Remarks | Sale | −28,000 | $23.75 | $665K | 0 |
| 2021-08-11 | Stuart Bryan See Remarks | Option exercise · Stock Option (right to buy) | −28,000 | 243,571 | ||
| 2021-08-10 | Stuart Bryan See Remarks | Option exercise | +32,000 | $7.84 | $251K | 32,000 |
| 2021-08-10 | Stuart Bryan See Remarks | Sale | −32,000 | $17.50 | $560K | 0 |
| 2021-08-10 | Stuart Bryan See Remarks | Option exercise · Stock Option (right to buy) | −32,000 | 271,571 | ||
| 2021-03-31 | Stuart Bryan See Remarks | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2021-01-25 | Stuart Bryan Chief Operating Officer | Grant or award · Stock Option (right to buy) | +134,376 | 134,376 | ||
| 2020-01-23 | Stuart Bryan Chief Operating Officer | Grant or award · Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2019-07-18 | Stuart Bryan Chief Operating Officer | Grant or award · Stock Option (right to buy) | +28,571 | 28,571 |
Page 1 of 1 · 11 trades